Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy.
This study prospectively compared the impact of cyclosporine A and tacrolimus on the development of cardiac allograft vasculopathy. By using serial intravascular ultrasound examinations, a trend toward a more pronounced progression was noted in the tacrolimus group in the first year after heart transplantation.
Klauss
V
V
Department of Internal Medicine, Klinikum Innenstadt, University of Munich, Germany.
König
A
A
Spes
C
C
Meiser
B
B
Rieber
J
J
Siebert
U
U
Regar
E
E
Pfeiffer
M
M
Reichart
B
B
Theisen
K
K
Mudra
H
H
D000293:Adolescent; D000328:Adult; D000368:Aged; D003327:Coronary Disease / Q000000981:diagnostic imaging / Q000209:etiology / Q000517:prevention & control*; D016572:Cyclosporine / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D016027:Heart Transplantation / Q000009:adverse effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D016559:Tacrolimus / Q000627:therapeutic use*; D014463:Ultrasonography
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D016559:Tacrolimus